LinKinVax
About:
LinKinVax operates as a clinical-stage biotechnology company.
Website: https://linkinvax.com/
Top Investors: In-Q-Tel, Geoffrey Duyk, Alain Tingaud, Giorgio Anania, André-Jacques Auberton-Hervé
Description:
LinKinVax operates as a clinical-stage biotechnology company. LinKinVax is developing an innovative protein-based vaccine platform that can accelerate availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI).
Total Funding Amount:
11.7M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2020-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-01-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai